Metastatic neoplasm

3 trials 1 recruiting MedDRA PT
3 Registered trials
1 Recruiting
3 Unique sponsors
2 Unique IMPs
3 Commercial trials
Drug classes (ATC)
ATC code not specified 3
Mechanism of action (INN-stem analysis)
Unknown / small molecule 2 substances
Phase I: 1 Phase I (First in Human): 2

Filter these 3 trials by country, sponsor, date range and more.

Open in Search → Gap analysis →
Show: 3 trials

Phase I

1 trial

Phase I (First in Human)

2 trials
  • Ipsen Pharma Commercial
    IPN01203
    2025-522184-15-00 2 countries 2026 n=38
    Recruiting
  • Takeda Development Center Americas Inc. Commercial
    TAK-280
    2023-504012-16-00 2 countries 2024 n=56
    Ended
Sponsor activity
SponsorTypeTrialsPhasesRecruiting
Amgen Inc. Commercial 1 Phase I 0
Ipsen Pharma Commercial 1 Phase I (First in Human) 1
Takeda Development Center Americas Inc. Commercial 1 Phase I (First in Human) 0
New trials by year
2024
1
2026
1
← All indication landscapes